MADISON HEIGHTS, Mich.,
June 22, 2017 /PRNewswire/--
InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the
"Company"), a leading national provider of infusion pumps and
related services for the healthcare industry in the United States and Canada, announced today that Darrell B. Montgomery and Christopher R. Sansone have been elected as new
members to the Company's Board of Directors at the 2017 annual
meeting of its stockholders on June 22,
2017. Messrs. Darrell
Montgomery and Christopher
Sansone will hold office until they stand for re-election at
InfuSystem's next annual shareholders meeting in 2018.
Darrell B. Montgomery
Darrell B. Montgomery brings nearly
30 years in operational management, technology sales, mergers &
acquisitions, consulting experience and leadership abilities
developed during his career as an executive. Mr. Montgomery began
his business career at Gemini Consulting as a senior consultant
leading client teams in telecommunications, computer services,
banking, and retail in both the United
States and Europe. Mr.
Montgomery spent 20 distinguished years at Dell Services, now NTT
Services, where he worked with large enterprises as well as small
companies principally focused on strategy and IT infrastructure.
Mr. Montgomery served as Director of Operations, Global Software
Solutions and held a senior role in the Commercial Solutions Group.
Mr. Montgomery then served as an Executive Director in charge of
establishing and leading the private equity channel working in
Healthcare and Travel & Leisure industries. Mr. Montgomery
previously served on the Board of Directors of Daegis, Inc., a
Nasdaq-listed company, and as member of the Audit Committee,
Compensation Committee and Nominating and Corporate Governance
Committees. Mr. Montgomery currently serves a Vice President,
Global Strategic Engagements for Atos, a global IT services firm.
Mr. Montgomery formerly served on active duty as a U.S. Marine
Corps Infantry Officer and is a Trustee of the U.S. Naval Academy
Athletic Foundation. Mr. Montgomery earned a Bachelor of Science in
History and General Engineering, with Distinction, from the
U.S. Naval Academy and a Masters of
Business Administration from Harvard Business
School.
Christopher R. Sansone
Christopher R. Sansone brings
extensive investment experience as both a managing partner and
founder of an investment partnership and various executive
leadership roles throughout his career. Mr. Sansone brings
experience and prospective as an analyst and as a managing partner
and founder of Sansone Capital Management, LLC. Prior to founding
Sansone Capital Management, LLC, Mr. Sansone held various roles
involving small capitalization companies, including his position as
an analyst and proprietary trader for Robotti & Company, LLC, a
broker-dealer specializing in small- and micro-capitalization
equities. Mr. Sansone served as a director on the board of EDAC
Technologies from 2011 to 2013 and on its Audit Committee and
Nominating and Governance Committee. Mr. Sansone has served as a
director on the board of Decorator Industries from 2011 to 2012.
Mr. Sansone was also a member of the committee of unsecured
creditors in Palm Harbor Homes from 2010 to 2011 and served as a
member on the OCA Incorporated Equity Committee from 2006 to 2007.
Mr. Sansone holds a Bachelor of Science in Economics from
Pace University.
Mr. Sansone serves as a Managing Partner of Sansone Advisors,
LCC, Sansone Capital Management, LLC and Christopher Sansone (collectively, the "Sansone
Group"), and is one of the Company's largest stockholders.
Accordingly, Mr. Sansone holds voting and dispositive power over
the Common Stock held by the Sansone Group. In addition, Mr.
Sansone has shared and voting dispositive power over the Common
Stock held by Sansone Partners, LP.
Management Discussion
Gregg
Lehman, Ph.D., executive chairman of the board of InfuSystem
commented, "We are pleased to welcome Darrell Montgomery and Chris Sansone to the Board. Darrell has built a
distinguished career with nearly 30 years of operational
management, technology sales, mergers & acquisitions,
consulting experience and executive leadership positions. Chris
brings extensive investment experience and various executive
leadership roles throughout his career and will assist the Board in
analyzing various corporate investment decisions and will add an
additional layer of financial analytics. Their extensive experience
and expertise will be an asset to the Board and provide us with
added depth to the Board's broad scope of professional
backgrounds."
About InfuSystem Holdings, Inc.
InfuSystem Holdings,
Inc. is a leading provider of infusion pumps and related services
to hospitals, oncology practices and other alternate site
healthcare providers. Headquartered in Madison Heights, Michigan, the Company
delivers local, field-based customer support and also operates
Centers of Excellence in Michigan,
Kansas, California, Texas, Georgia and Ontario,
Canada. The Company's stock is traded on the NYSE MKT under
the symbol INFU.
Forward-Looking Statements
Statements made in
this press release that are not historical facts are considered to
be forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended (the "Securities Act") and
Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "should," "plan," "expect,"
"strategy," "future," "likely," variations of such words, and other
similar expressions, as they relate to the Company, are intended to
identify forward-looking statements. However, the absence of these
words or similar expressions does not mean that a statement is not
forward-looking. Forward-looking statements include statements
relating to future actions, business plans, objectives and
prospects, future operating or financial performance. In connection
with the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995, the Company is identifying certain
factors that could cause actual results to differ, perhaps
materially, from those indicated by these forward-looking
statements. Those factors, risks and uncertainties include, but are
not limited to, potential changes in overall healthcare
reimbursement, including CMS competitive bidding, sequestration,
concentration of customers, increased focus on early detection of
cancer, competitive treatments, dependency on Medicare Supplier
Number, availability of chemotherapy drugs, global financial
conditions, changes and enforcement of state and federal laws,
natural forces, competition, dependency on suppliers, risks in
acquisitions & joint ventures, U.S. Healthcare Reform,
relationships with healthcare professionals and organizations,
technological changes related to infusion therapy, dependency on
websites and intellectual property, the ability of the Company to
successfully integrate acquired businesses, dependency on key
personnel, dependency on banking relations and covenants, and other
risks associated with our common stock, as well as any litigation
to which the Company may be involved in from time to time; and
other risk factors as discussed in the Company's annual report on
Form 10-K for the year ended December 31,
2016 and in other filings made by the Company from time to
time with the Securities and Exchange Commission, including our
quarterly reports on Form 10-Q. Our annual report on Form 10-K is
available on the SEC's EDGAR website at
www.sec.gov, and a copy may also be obtained by
contacting the Company. All forward-looking statements made in this
press release speak only as of the date hereof. We do not intend,
and do not undertake any obligation, to update any forward-looking
statements to reflect future events or circumstances after the date
of such statements, except as required by law.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
CONTACT:
|
Gregg
Lehman
|
|
Executive Chairman –
InfuSystem Holdings, Inc.
|
|
615-567-5462
|
|
|
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
Lytham Partners,
LLC
|
|
602-889-9700
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/infusystem-announces-the-election-of-darrell-montgomery-and-christopher-sansone-to-board-of-directors-300478616.html
SOURCE InfuSystem Holdings, Inc.